Furthermore, studies by ourselves and others (including previous studies and the present study) show that Visfatin reduces the sensitivity of CRC cells to chemotherapeutic drugs, e.g., capecitabine and 5-FU [20,28,29]. The gene discussed is NAMPT; the disease is colorectal carcinoma.